BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12183144)

  • 1. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area.
    Cornet M; Fleury L; Maslo C; Bernard JF; Brücker G;
    J Hosp Infect; 2002 Aug; 51(4):288-96. PubMed ID: 12183144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
    Morgan J; Wannemuehler KA; Marr KA; Hadley S; Kontoyiannis DP; Walsh TJ; Fridkin SK; Pappas PG; Warnock DW
    Med Mycol; 2005 May; 43 Suppl 1():S49-58. PubMed ID: 16110792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
    Klingspor L; Saaedi B; Ljungman P; Szakos A
    Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.
    Nucci M; Garnica M; Gloria AB; Lehugeur DS; Dias VC; Palma LC; Cappellano P; Fertrin KY; Carlesse F; Simões B; Bergamasco MD; Cunha CA; Seber A; Ribeiro MP; Queiroz-Telles F; Lee ML; Chauffaille ML; Silla L; de Souza CA; Colombo AL
    Clin Microbiol Infect; 2013 Aug; 19(8):745-51. PubMed ID: 23009319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
    Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of invasive fungal disease in haematologic patients.
    Souza L; Nouér SA; Morales H; Simões B; Solza C; Queiroz-Telles F; Nucci M
    Mycoses; 2021 Mar; 64(3):252-256. PubMed ID: 33141969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital.
    Garnaud C; Brenier-Pinchart MP; Thiebaut-Bertrand A; Hamidfar R; Quesada JL; Bosseray A; Lebeau B; Mallaret MR; Maubon D; Saint-Raymond C; Pinel C; Hincky V; Plantaz D; Cornet M; Pelloux H
    J Infect; 2012 Dec; 65(6):559-67. PubMed ID: 22902944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
    Robin C; Cordonnier C; Sitbon K; Raus N; Lortholary O; Maury S; Peffault de la Tour R; Bretagne S; Bastuji-Garin S;
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):354-361. PubMed ID: 30268782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
    Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA
    Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).
    Lortholary O; Gangneux JP; Sitbon K; Lebeau B; de Monbrison F; Le Strat Y; Coignard B; Dromer F; Bretagne S;
    Clin Microbiol Infect; 2011 Dec; 17(12):1882-9. PubMed ID: 21668573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002).
    Fourneret-Vivier A; Lebeau B; Mallaret MR; Brenier-Pinchart MP; Brion JP; Pinel C; Garban F; Pison C; Hamidfar R; Plantaz D; Pelloux H; Grillot R
    J Hosp Infect; 2006 Jan; 62(1):22-8. PubMed ID: 16257084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
    Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation.
    Koldehoff M; Beelen DW; Elmaagacli AH
    Transpl Infect Dis; 2013 Oct; 15(5):533-9. PubMed ID: 23890253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
    Upton A; Kirby KA; Carpenter P; Boeckh M; Marr KA
    Clin Infect Dis; 2007 Feb; 44(4):531-40. PubMed ID: 17243056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive fungal infections after allogeneic hematopoietic stem cell transplantation and related risk factors].
    Wang ZY; Jiang EL; Zhang P; Wang H; Bao YS; Wang M; Feng SZ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):618-22. PubMed ID: 18549641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The epidemiological surveillance network for nosocomial invasive aspergillosis of the Assistance Publique-Hôpitaux de Paris].
    Bocquet P; Patris S; Dumartin C; Gottot S; Rykner G; Brücker G
    Ann Med Interne (Paris); 1995; 146(2):79-83. PubMed ID: 7598346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
    Steinbach WJ; Marr KA; Anaissie EJ; Azie N; Quan SP; Meier-Kriesche HU; Apewokin S; Horn DL
    J Infect; 2012 Nov; 65(5):453-64. PubMed ID: 22898389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.